BioMicrofluidics & Nanotechnology Lab

Our mission is to develop advanced tools and molecular biomarkers for quantitative analysis of dynamic and heterogeneous molecular processes underlying complex biological systems, especially cancer. Drawing on chemistry, molecular/cell biology, engineering, and materials science, we strive to advance quantitative biology and personalized medicine through technology innovation and translational research. For more details please visit our Research page.


Postdoc Position in Microfluidics

A postdoc position is available in our lab, starting in Fall 2016. The project is to develop new microfluidic assays for ultrasensitive detection of blood-based biomarkers in clinical samples. A recent Ph.D. in chemistry, biochemistry, molecular/cell biology, bioengineering or biomedical sciences is required. The applicants should have strong expertise in one or several of the following fields: microfluidics, immunoassays, cell culture and assays, and molecular biology techniques. Please send a CV, statement of interest, and the contact information of three references to and apply via

We are inviting postdoctoral scholars, graduate and undergraduate students to join us. For details, please visit the Position page.


Funding Sources

Our research is currently supported by the NIH Common Fund, National Cancer Institute (NCI) Innovative Molecular Analysis Technologies Program (IMAT), the J.R. & Inez Jay Fund, NIH/NIGMS K-INBRE, NIH COBRE Center for Molecular Analysis of Disease Pathways (CMADP), NIH COBRE Center for Cancer Experimental Therapeutics (CCET) and the University of Kansas.


One of 34 U.S. public institutions in the prestigious Association of American Universities
Nearly $290 million in financial aid annually
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
23rd nationwide for service to veterans —"Best for Vets," Military Times
KU Today